The indication of protopic is moderate to severe atopic dermatitis in non-immunocompromised patients who do not or cannot tolerate conventional therapies. The mechanism is inhibits T-Lymphocyte activation. The efficiency is various among the vitiligo patients. This article shows the study of the efficiency of the protopic.
The protopic‘s trade name is tacrolimus ointment. It is produced by the pharmaceuticals company of the Astellas. It is approved by the American food production and the Food and Drug Administration (FDA) by using treat the atopic dermatitis. This medicine is a kind of immunosuppressant. Based on a lot of medical academics reports and medical treatment, the protopic not only can use for atopic dermatitis, but also have a good effect on vitiligo’s treatment.
There are two different concentrations for protopic, the concentration is 0.03% and 0.1% respectively. For those children whose age below the twelve should use 0.03% concentration’s protopic, above the twelve years should use 0.1% concentration. The protopic need to apply on the skin twice a day, the interval should be eight hours. Some scholars study fifty-two targeted white spots from fifty cases of vitiligo patient, the targeted white spots area’s range from 1.8 to 30 square centimeters. The treatment of observation is three months. The results showed that six patients are treated, the treat rate is 11.54%, excellent to show result were twenty persons (38.46%), an effective result were twenty-one persons (40.38%), No effect were five persons (9.62%). The nose and surrounding of the eyes have the best treatment result than the cheek area. Only few cases of patients will feel itchiness, burning during the course of treatment.